159 related articles for article (PubMed ID: 31632549)
41. [Analysis of clinical characteristics and prognostic factors in patients with non-Hodgkin lymphoma and HBV infection].
Zhang L; Yuan XL; Jiang L; Yang J; Guo JM; Shi J; Lei PC; Zhang Y; Zhu ZM
Zhonghua Xue Ye Xue Za Zhi; 2018 Jul; 39(7):563-568. PubMed ID: 30122015
[No Abstract] [Full Text] [Related]
42. [Analysis of proliferative lesions of haematopoietic and lymphoid tissue in the female productive tract].
Chen DB; Zhang H; Zhang YH; Wang Y; Song QJ; Yang SM; Cui H; Zhao Y; Fang XZ; Shen DH
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):263-269. PubMed ID: 29747272
[No Abstract] [Full Text] [Related]
43. [Clinicopathological features and treatment outcome of 37 cases of primary thyroid lymphoma].
Zhou Y; Xu X; Xu H; Cui GH; Zhang L
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Oct; 32(20):1551-1556. PubMed ID: 30400705
[No Abstract] [Full Text] [Related]
44. Utility of Bone Marrow Biopsy and Aspirate for Staging of Diffuse Large B Cell Lymphoma in the Era of Positron Emission Tomography With 2-Deoxy-2-[Fluorine-18]fluoro-deoxyglucose Integrated With Computed Tomography.
Vishnu P; Wingerson A; Lee M; Mandelson MT; Aboulafia DM
Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):631-636. PubMed ID: 28684378
[TBL] [Abstract][Full Text] [Related]
45. [Clinical analysis of 42 cases of primary malignant melanoma in female genital tract].
An JS; Wu LY; Li N; Li B; Yu GZ; Liu LY
Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):320-4. PubMed ID: 17673044
[TBL] [Abstract][Full Text] [Related]
46. [Primary testicular non-Hodgkin's lymphoma: clinical analysis of 21 cases].
Zhang C; Wang XP; Ying ZT; Zheng W; Xie Y; Lin NJ; Ping LY; Liu WP; Deng LJ; Song YQ; Zhu J
Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(28):2209-11. PubMed ID: 24169330
[TBL] [Abstract][Full Text] [Related]
47. Primary parotid lymphoma: the effect of International Prognostic Index on outcome.
Sarris AH; Papadimitrakopoulou V; Dimopoulos MA; Smith T; Pugh W; Ha CS; McLaughlin P; Callender D; Cox J; Cabanillas F
Leuk Lymphoma; 1997 Jun; 26(1-2):49-56. PubMed ID: 9250787
[TBL] [Abstract][Full Text] [Related]
48. Total lesion glycolysis in positron emission tomography is a better predictor of outcome than the International Prognostic Index for patients with diffuse large B cell lymphoma.
Kim TM; Paeng JC; Chun IK; Keam B; Jeon YK; Lee SH; Kim DW; Lee DS; Kim CW; Chung JK; Kim IH; Heo DS
Cancer; 2013 Mar; 119(6):1195-202. PubMed ID: 23212736
[TBL] [Abstract][Full Text] [Related]
49. [Comparison the efficacy and prognosis of different first-line treatment for elderly diffuse large B-cell lymphoma].
Liu P; Jiang SY; He XH; Qin Y; Gui L; Zhou SY; Yang JL; Yang S; Wen TY; Shi YK
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):234-241. PubMed ID: 32252203
[No Abstract] [Full Text] [Related]
50. [Prognostic factors in patients with primary non-Hodgkin's lymphoma of the tonsil].
Gao Y; Li Y; Yuan Z; Zhao L; Liu X; Gu D; Qian T; Yu Z
Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):483-5. PubMed ID: 12485504
[TBL] [Abstract][Full Text] [Related]
51. [Clinicpathological features and survival of patients with AIDS related non-Hodgkin's lymphoma].
Sun KY; Gui XE; Deng D; Xiong Y; Deng LP; Gao SC; Zhang YX
Zhonghua Xue Ye Xue Za Zhi; 2017 Feb; 38(2):97-101. PubMed ID: 28279031
[No Abstract] [Full Text] [Related]
52. Ki-67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma.
Räty R; Franssila K; Joensuu H; Teerenhovi L; Elonen E
Eur J Haematol; 2002 Jul; 69(1):11-20. PubMed ID: 12270057
[TBL] [Abstract][Full Text] [Related]
53. Localized primary gastrointestinal diffuse large B cell lymphoma received a surgical approach: an analysis of prognostic factors and comparison of staging systems in 101 patients from a single institution.
Zhang S; Wang L; Yu D; Shen Y; Cheng S; Zhang L; Qian Y; Shen Z; Li Q; Zhao W
World J Surg Oncol; 2015 Aug; 13():246. PubMed ID: 26271948
[TBL] [Abstract][Full Text] [Related]
54. Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma.
Han Y; Yang J; Liu P; He X; Zhang C; Zhou S; Zhou L; Qin Y; Song Y; Sun Y; Shi Y
Oncologist; 2019 Nov; 24(11):e1251-e1261. PubMed ID: 30952824
[TBL] [Abstract][Full Text] [Related]
55. Prognostic significance of the immunophenotype versus the International Prognostic Index in aggressive non-Hodgkin's lymphoma.
Intragumtornchai T; Rotnakkarin P; Sutcharitchan P; Wannagrairoj P
Clin Lymphoma; 2003 Jun; 4(1):52-5. PubMed ID: 12837156
[TBL] [Abstract][Full Text] [Related]
56. Non-Hodgkin's lymphoma of the stomach: treatment outcomes for 57 patients over a 20-year period.
Ho CL; Hsieh AT; Dai MS; Chen YC; Kao WY; Chao TY
J Chin Med Assoc; 2005 Jan; 68(1):11-5. PubMed ID: 15742857
[TBL] [Abstract][Full Text] [Related]
57. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
[TBL] [Abstract][Full Text] [Related]
58. Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab era.
Huang YC; Liu CY; Lu HJ; Liu HT; Hung MH; Hong YC; Hsiao LT; Gau JP; Liu JH; Hsu HC; Chiou TJ; Chen PM; Tzeng CH; Yu YB
Ann Hematol; 2013 Nov; 92(11):1513-20. PubMed ID: 23775580
[TBL] [Abstract][Full Text] [Related]
59. Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors.
Bosch F; López-Guillermo A; Campo E; Ribera JM; Conde E; Piris MA; Vallespí T; Woessner S; Montserrat E
Cancer; 1998 Feb; 82(3):567-75. PubMed ID: 9452276
[TBL] [Abstract][Full Text] [Related]
60. Malignant lymphoma and granulocytic sarcoma of the uterus and vagina. A clinicopathologic analysis of 27 cases.
Harris NL; Scully RE
Cancer; 1984 Jun; 53(11):2530-45. PubMed ID: 6585265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]